N-palmitoyl-S-[2,3-bis(palmitoyloxy)propyl]-Cys-Ser-Lys-Lys-Lys-Lys

Term ID

CHEBI:134411

Synonyms

N-hexadecanoyl-S-[2,3-bis(hexadecanoyloxy)propyl]-Cys-Ser-Lys-Lys-Lys-Lys
N-Palmitoyl-S-(2,3-bis(palmitoyloxy)propyl)cysteinyl-seryl-lysyl-lysyl-lysyl-lysine
Pam(3)-cys-ser-(lys)(4)
Pam3CSK4
S-[2,3-bis(hexadecanoyloxy)propyl]-N-tetradecanoyl-L-cysteinyl-L-seryl-L-lysyl-L-lysyl-L-lysyl-L-lysine
Tripalmitoyl-cysteinyl-seryl-lysine(4)

Definition

A triacyl lipopeptide that is N-palmitoyl-Cys-Ser-Lys-Lys-Lys-Lys in which the side-chain thiol hydrogen on the Cys residue has been replaced by a 2,3-bis(palmitoyloxy)propyl group.

References

cas:112208-00-1
pubmed:17578764
pubmed:18644025
pubmed:19617307
pubmed:20081527
pubmed:20808895
pubmed:22351935
pubmed:23073139
pubmed:23298864
pubmed:23826757
pubmed:24375077
pubmed:24489933
pubmed:24799523
pubmed:25378593
pubmed:25398056
pubmed:25738770
pubmed:25912722
pubmed:26026246
pubmed:26190752
pubmed:26927383
pubmed:26974438
pubmed:27563808
pubmed:27620721
pubmed:27794068
pubmed:28078083
pubmed:28288677
pubmed:28374588
pubmed:28407632
pubmed:28419983
pubmed:28445714

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from N-palmitoyl-S-[2,3-bis(palmitoyloxy)propyl]-Cys-Ser-Lys-Lys-Lys-Lys

Phenotype where environments contain N-palmitoyl-S-[2,3-bis(palmitoyloxy)propyl]-Cys-Ser-Lys-Lys-Lys-Lys

Phenotype modified by environments containing N-palmitoyl-S-[2,3-bis(palmitoyloxy)propyl]-Cys-Ser-Lys-Lys-Lys-Lys

Phenotype affecting N-palmitoyl-S-[2,3-bis(palmitoyloxy)propyl]-Cys-Ser-Lys-Lys-Lys-Lys

Human Disease Model